Jennifer Thompson, Medtronic’s vice president of U.S. aortic sales, detailed how AI is transforming medical device commercialization during a fireside chat at Reuters’ MedTech conference. The technology is helping teams identify patients, optimize their sales deployment and discover care bottlenecks.
This technological shift not only boosts efficiency and profitability for pharmaceutical companies but also speeds up the delivery of innovative therapies to patients.
Zelis highlights how employers, payers, and consumers are integrating digital tools to manage healthcare costs.
Lack of automation is the top challenge facing commercialization teams, according to a survey of executives at U.S.-based pharma companies. The survey was conducted in late 2023 and results were reported this month.
At an event styled after the TV show but kinder and gentler, OSF HealthCare employees get 15 minutes to pitch their ideas to subject matter experts, stakeholders and other members of the community. They use the presentation to share where they are in the process and what resources they need to validate their concepts and network.
Called the Innovator Community Expansion Initiative, the main goal of the effort is to pinpoint and remove obstacles keeping underrepresented groups, like women, out of the innovation process. The initiative will promote networking and education about the path to commercialization.
The high cost of gene and cell therapies will make it critical for companies to provide higher levels of support for healthcare providers and especially for patients through access, reimbursement, and financing.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.